Navigation Links
Virginia Woolf and Neuropsychiatry
Date:1/25/2013

Virginia Woolf and Neuropsychiatry, written by Maxwell Bennett, one of the leaders in the field of neurosciences, provides an explanation of the symptoms and untimely suicide of one of literature's greatest authors, Virginia Woolf. The sources used are letters and statements from Woolf herself, the literature she wrote and comments, letters and other documentation that refers to her mental state and her medical status. The author uses current insights into depression, the mental consequences of child abuse and drug interactions/effects to examine her life.

The second part of the book provides a neuropsychiatric analysis of the state of present knowledge concerning what goes awry in the functioning of the brain in depression, particularly leading to suicide. Five essays, aimed at specialists in neuropsychiatry, show how far we have probed brain functions related to major psychiatric problems.

Maxwell Bennett said: "Because of her literary genius, we find in her novels, plays, critical reviews, autobiographical sketches and diaries an unparalleled insight into the mind of someone destined to end their life. These offer those concerned with mitigating the incidence of suicide a unique opportunity to consider the circumstances and familial burdens that promote severe depression and so design programs that will ameliorate them."

M. R. Bennett AO is Professor of Neuroscience and University Chair at the University of Sydney, Founding Director of the Brain and Mind Research Institute and Adjunct Professor of Neuropsychiatry. He is the author of many papers and books in neuroscience and neuropsychiatry, including The Idea of Consciousness (1997) and a History of the Synapse (2001) as well as more recently Philosophical Foundations of Neuroscience (2003) and History of Cognitive Neuroscience (2008) with his colleague Peter Hacker. Maxwell Bennett is the recipient of numerous awards for his research in neuroscience.


'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert  

Page: 1

Related biology news :

1. Virginia Tech computer scientists develop new way to study molecular networks
2. TESARO and Virginia G. Piper Cancer Center announce first patient in clinical trial of TSR-011
3. Old deeds, witness trees offer glimpse of pre-settlement forest in West Virginia
4. Scientific meeting at Virginia Tech will make more than $2 million economic impact
5. Virginia Tech and University of Tuscia lead team to unravel origin of devastating kiwifruit bacterium
6. Biology professor secures grant to save West Virginias primary natural history collection
7. Virginia Tech announces 2012 football helmet ratings; 2 more added to the 5-star mark
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Virginia Woolf and Neuropsychiatry
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
(Date:3/22/2016)... PUNE, India , March 22, 2016 ... new market research report "Electronic Sensors Market for ... Fingerprint, Proximity, & Others), Application (Communication & ... and Geography - Global Forecast to 2022", ... consumer industry is expected to reach USD ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf ... join the faculty of the University of North Carolina Kenan-Flagler Business School ... and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, ... launch of their brand, UP4™ Probiotics, into Target stores nationwide. The company, which ... to add Target to its list of well-respected retailers. This list includes such ...
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
Breaking Biology Technology: